Zobrazeno 1 - 10
of 245
pro vyhledávání: '"Xiaowei, Qi"'
Publikováno v:
BMC Biotechnology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Homocysteine (HCY) is a sulfur-containing amino acid that is an independent or important risk factor for the occurrence of many chronic diseases and is one of the most important indicators for determining health risks. However, ex
Externí odkaz:
https://doaj.org/article/82d1d1b57feb4c63a749f8d8ff61dbfa
Autor:
Cheng Wang, Long Yuan, Xiujuan Wu, Yan Wang, Hao Tian, Guozhi Zhang, Andi Wan, Siyi Xiong, Chengfang Wang, Yuqin Zhou, Dandan Ma, Yangqiu Bao, Man Qu, Jun Jiang, Yi Zhang, Xiaowei Qi
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-10 (2024)
Abstract Background Previous studies have shown that the addition of platinum to neoadjuvant chemotherapy (NAC) improved outcomes for patients with triple-negative breast cancer (TNBC). However, no studies have assessed the efficacy and safety of the
Externí odkaz:
https://doaj.org/article/15696dfb13c44806a9606edb08ab04bc
Publikováno v:
Meitan kexue jishu, Vol 52, Iss 5, Pp 191-208 (2024)
Scandium (Sc), which has a high melting point and a low density, is widely used in lighting, alloys, ceramics, catalysts, and other industrial fields. Under a specific geological condition, Sc could be enriched in certain coal. As one of strategic me
Externí odkaz:
https://doaj.org/article/17be534fc90c41a89623afc0a601a0a2
Publikováno v:
BMC Biotechnology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Venous thromboembolism (VTE), is a noteworthy complication in individuals with gastric cancer, but the current diagnosis and treatment methods lack accuracy. In this study, we developed a t-PAIC chemiluminescence kit and employed
Externí odkaz:
https://doaj.org/article/37ba59f4364e4bcc8ed389691c499877
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-20 (2024)
Abstract Tumor is a local tissue hyperplasia resulted from cancerous transformation of normal cells under the action of various physical, chemical and biological factors. The exploration of tumorigenesis mechanism is crucial for early prevention and
Externí odkaz:
https://doaj.org/article/cb282662748b4c8b99b0f11b3a6c16c0
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Breast cancer is the most common malignant tumor in women. Due to the high heterogeneity of breast cancer cells, traditional in vitro research models still have major limitations. Therefore, it is urgent to establish an experimental model that can ac
Externí odkaz:
https://doaj.org/article/efad9b3accaf4084aa61f9bb17ebc97a
Autor:
Wei Li, Chuanyu Yang, Zhuo Cheng, Yuanyuan Wu, Sihan Zhou, Xiaowei Qi, Yi Zhang, Jinhui Hu, Mingjin Xie, Ceshi Chen
Publikováno v:
MedComm, Vol 5, Iss 8, Pp n/a-n/a (2024)
Abstract Colorectal cancer (CRC) is one of the most common malignancies worldwide. In the clinical realm, platinum‐based drugs hold an important role in the chemotherapy of CRC. Nonetheless, a multitude of patients, due to tumor protein 53 (TP53) g
Externí odkaz:
https://doaj.org/article/b58a674ecc524aa083d0d3a7f9c21779
Autor:
Yan Liang, Jing Liu, Jia Ge, Qiyun Shi, Guozhi Zhang, Andi Wan, Tao Luo, Hao Tian, Linjun Fan, Shushu Wang, Li Chen, Peng Tang, Kai Zhu, Jun Jiang, Xiuwu Bian, Yi Zhang, Xiaowei Qi
Publikováno v:
EClinicalMedicine, Vol 71, Iss , Pp 102585- (2024)
Summary: Background: Anlotinib is a new type of tyrosine kinase inhibitor that targets vascular endothelial growth factor receptors 1/2/3, platelet-derived growth factor receptors α/β, and fibroblast growth factor receptors 1–4 and c-Kit, with a
Externí odkaz:
https://doaj.org/article/9b025f9f2bc945d3bf412a05fed96ed7
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-11 (2023)
Abstract Human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC) is a highly aggressive subtype associated with poor prognosis. The advent of HER2-targeted drugs, including monoclonal antibodies, tyrosine-kinase inhibitors (TKIs)
Externí odkaz:
https://doaj.org/article/c29fc4d05fb3411cb15ea3610109f2ec
Autor:
Yu Wang, Qianmei Wang, Xiaowen Wang, Pu Yao, Qing Dai, Xiaowei Qi, Ming Yang, Xiao Zhang, Rong Huang, Jing Yang, Qian Wang, Peiyuan Xia, Dinglin Zhang, Fengjun Sun
Publikováno v:
Journal of Nanobiotechnology, Vol 21, Iss 1, Pp 1-22 (2023)
Abstract Background Although stimuli-responsive nanoplatforms were developed to deliver immunogenic cell death (ICD) inducers to enhance cancer immunotherapy, the complete release of ICD inducers into the tumor microenvironment (TME) was limited by t
Externí odkaz:
https://doaj.org/article/c372a05a9f6042498fd493188a0876ca